Risk Factors and Nursing Countermeasures of Ventilator-Associated Pneumonia in Children in the Intensive Care Unit

Rong Chen, Yu Liu, Xiaohong Zhang, Qin Yang, Xiao WangJournal of Healthcare Engineering 2022 · DOI

TL;DR

This study identifies key risk factors for Ventilator-Associated Pneumonia (VAP) in pediatric intensive care units (PICUs), finding that prolonged mechanical ventilation, invasive procedures, and the use of hormones and antacids significantly increase VAP risk. The research emphasizes the need for targeted nursing interventions to mitigate these factors and improve patient outcomes.

What Problem Does This Paper Address?

Ventilator-Associated Pneumonia (VAP) is a serious complication for critically ill children requiring mechanical ventilation, leading to increased morbidity, mortality, longer hospital stays, and higher healthcare costs. While VAP is a known issue, understanding the specific risk factors and developing effective, targeted nursing strategies within the unique context of pediatric intensive care remains an ongoing challenge. This paper aims to clarify these risk factors and propose actionable nursing countermeasures to reduce VAP incidence and improve prognosis in this vulnerable population.

Methods

The researchers conducted a retrospective analysis of clinical data from 155 children admitted to the pediatric ICU between October 2018 and October 2020 who required mechanical ventilation. Patients were divided into two groups: those who developed VAP and those who did not. A univariate analysis was performed to identify potential risk factors, followed by a multivariate logistic regression model to pinpoint independent risk factors for VAP. Statistical analysis included t-tests for continuous data and chi-squared tests for categorical data, with a significance level of P < 0.05.

Datasets

The study utilized a dataset comprising the clinical data of 155 children admitted to the pediatric ICU of Xiangyang Central Hospital. This data included general patient demographics, underlying diseases, experience of blood transfusion, nutritional status, diagnostic information, and treatment details such as nutritional support methods, intubation methods, and the application of antibiotics, hormones, and antacids. The data was collected retrospectively from October 2018 to October 2020. No new datasets were introduced.

Key Insights and Ideas

  • VAP is a significant problem in PICUs: The study highlights a substantial VAP incidence rate of 31.62% in their pediatric ICU cohort, underscoring the critical need for prevention strategies.
  • Gram-negative bacteria dominate: The primary pathogens identified in VAP cases were Gram-negative bacteria, a finding consistent with broader research and important for guiding antibiotic selection.
  • Beyond duration: specific interventions matter: While prolonged mechanical ventilation is a known risk, the study pinpoints invasive procedures and the use of specific medications (hormones and antacids) as independent risk factors, offering more granular targets for intervention.
  • The cost of VAP is substantial: The VAP group experienced significantly longer hospital stays and considerably higher hospitalization costs, emphasizing the economic burden of this complication.
  • Targeted nursing is key: The paper strongly advocates for tailored nursing interventions that directly address the identified risk factors, moving beyond general care to specific preventative actions.

Key Results

  • Incidence: 49 out of 155 children (31.62%) developed VAP.
  • Pathogens: Gram-negative bacteria accounted for the majority of identified pathogens (61.43%).
  • Independent Risk Factors: Multivariate logistic regression identified the following as independent risk factors for VAP:
  • Duration of mechanical ventilation (OR = 3.428)
    • Invasive operations (OR = 4.464)
    • Application of hormones (OR = 8.474)
    • Application of antacids (OR = 4.641)
  • Treatment Outcomes:
    • The VAP group had a significantly longer hospital stay (20.92 ± 4.16 days) compared to the non-VAP group (15.24 ± 3.77 days) (P < 0.001).
  • Hospitalization costs were substantially higher for the VAP group (4.58 ± 1.04 thousand Yuan) than for the non-VAP group (3.32 ± 0.43 thousand Yuan) (P < 0.001).

Limitations and Future Work

Limitations: * Retrospective Design: The study's retrospective nature means it can identify associations but cannot definitively establish causality. * Single Center: The findings are from a single hospital, which may limit generalizability to other PICU settings with different patient populations or care practices. * Age Range: The inclusion criteria focused on children aged 3-12 years, so the findings may not directly apply to neonates or older children.

Future Work: The authors suggest that future research should focus on developing and evaluating targeted nursing countermeasures to reduce the duration of mechanical ventilation, minimize invasive procedures, and optimize the rational use of hormones and antacids. Further prospective studies could provide stronger evidence for the effectiveness of these interventions.

Summary updated

Abstract

Children admitted to the pediatric ICU have a high VAP incidence. The primary pathogenic bacteria are Gram-negative bacteria. As the occurrence of VAP is closely related to a variety of factors, we should take targeted nursing countermeasures to reduce the duration of mechanical ventilation and the frequency of invasive operations and use the hormone and antacids rationally to reduce the risk of VAP and improve the prognosis.
BibTeX
@article{chen2022risk,
  author = {Rong Chen and Yu Liu and Xiaohong Zhang and Qin Yang and Xiao Wang},
  title = {{Risk Factors and Nursing Countermeasures of Ventilator-Associated Pneumonia in Children in the Intensive Care Unit}},
  journal = {Journal of Healthcare Engineering},
  year = {2022},
  doi = {10.1155/2022/9055587},
}
Figure